These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12777237)

  • 21. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
    Johnson TM; Jones K; Williford WO; Kutner MH; Issa MM; Lepor H
    J Urol; 2003 Jul; 170(1):145-8. PubMed ID: 12796667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign prostatic hyperplasia (BPH).
    Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474
    [No Abstract]   [Full Text] [Related]  

  • 23. Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin for bladder outlet obstruction.
    Baldwin KC; Ginsberg PC; Harkaway RC
    Urol Int; 2001; 66(2):84-8. PubMed ID: 11223749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benign prostatic hyperplasia.
    Doherty AP
    Hosp Med; 2003 Feb; 64(2):114. PubMed ID: 12619342
    [No Abstract]   [Full Text] [Related]  

  • 25. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2000; (2):3-5. PubMed ID: 11186726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function.
    Kaplan SA
    Urology; 2004 Mar; 63(3):428-34. PubMed ID: 15028431
    [No Abstract]   [Full Text] [Related]  

  • 27. [Conservative treatment of benign prostatic hyperplasia].
    Romics I
    Orv Hetil; 2008 Oct; 149(40):1875-80. PubMed ID: 18815106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): new targets for new combination therapies?
    Sciarra A
    Eur Urol; 2007 Jun; 51(6):1485-7. PubMed ID: 17275984
    [No Abstract]   [Full Text] [Related]  

  • 29. Should patients with benign prostatic hypertrophy stop taking doxazosin in the light of the ALLHAT study?
    Cheng TO
    Int J Cardiol; 2006 Feb; 107(2):275-6. PubMed ID: 16412808
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
    Kaplan SA; McConnell JD; Roehrborn CG; Meehan AG; Lee MW; Noble WR; Kusek JW; Nyberg LM;
    J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the medical management of benign prostatic hyperplasia.
    Jewett MA; Klotz LH;
    CMAJ; 2007 Jun; 176(13):1850-1. PubMed ID: 17576985
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epidemiology of lower urinary tract symptoms and use of doxazosin in the treatment of early stages of benign prostate hyperplasia].
    Nurullaev RB
    Lik Sprava; 2004; (3-4):101-3. PubMed ID: 15318840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
    MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terazosin vs finasteride for BPH.
    Zacks M
    J Fam Pract; 1996 Dec; 43(6):533. PubMed ID: 8969692
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
    Agha AH; Roy JB; Culkin DJ; Lyon K
    Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of benign prostatic hyperplasia.
    Walsh PC
    N Engl J Med; 1996 Aug; 335(8):586-7. PubMed ID: 8678937
    [No Abstract]   [Full Text] [Related]  

  • 37. The place of pharmacologic treatment in benign prostatic hyperplasia.
    Caine M
    Semin Urol; 1985 Nov; 3(4):311-6. PubMed ID: 2441447
    [No Abstract]   [Full Text] [Related]  

  • 38. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
    J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A current review of medical therapy for benign prostatic hyperplasia.
    Brown GA; Sussman DO
    J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S11-6. PubMed ID: 15038398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical management of benign prostatic hyperplasia--are two drugs better than one?
    Vaughan ED
    N Engl J Med; 2003 Dec; 349(25):2449-51. PubMed ID: 14681512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.